These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 9739503)

  • 21. [State of the art: low-molecular-weight heparin and beyond].
    Cimminiello C; Casali G; Vitali L
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):61-5. PubMed ID: 11253343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.
    Camporese G; Bernardi E; Prandoni P; Noventa F; Verlato F; Simioni P; Ntita K; Salmistraro G; Frangos C; Rossi F; Cordova R; Franz F; Zucchetta P; Kontothanassis D; Andreozzi GM;
    Ann Intern Med; 2008 Jul; 149(2):73-82. PubMed ID: 18626046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Thromboprophylaxis in patients with previous thromboembolic disease who require major orthopedic surgery].
    Peidro L; Casals F; Real I; Poggio D
    Med Clin (Barc); 2008 Nov; 131 Suppl 2():25-8. PubMed ID: 19087847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic drugs for older subjects. Guidelines formulated jointly by the Italian Societies of Haemostasis and Thrombosis (SISET) and of Gerontology and Geriatrics (SIGG).
    Di Minno G; Tufano A; Cerbone AM
    Nutr Metab Cardiovasc Dis; 2001 Feb; 11(1):41-62. PubMed ID: 11383324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low molecular weight heparins for venous thromboembolism.
    Drug Ther Bull; 1998 Apr; 36(4):25-9. PubMed ID: 9684414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombotic defense during the postoperative period. Clinical documentation of low molecular weight heparin.
    Welzel D; Wolf H; Koppenhagen K
    Arzneimittelforschung; 1988 Jan; 38(1):120-3. PubMed ID: 2835055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Questionnaire on venous thromboembolism prevention by low molecular weight heparin in medical environment].
    Ambrosi P; Calise G; Villani P; Luccioni R; Bouvenot G
    Presse Med; 2000 Sep; 29(16):1447-50. PubMed ID: 11039083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assessment of complications of major orthopedic surgery: comparison of indobufen, calcium heparin, and low molecular heparin].
    Borghi B; Bassi A; Grazia M; Feoli MA; Pignotti E
    Minerva Anestesiol; 1996 Mar; 62(3):93-100. PubMed ID: 8767154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombotic drugs: part I.
    Gallus AS; Hirsh J
    Drugs; 1976; 12(1):41-68. PubMed ID: 789043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.
    Donath L; Lützner J; Werth S; Kuhlisch E; Hartmann A; Günther KP; Weiss N; Beyer-Westendorf J
    Br J Clin Pharmacol; 2012 Dec; 74(6):947-58. PubMed ID: 22515679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Venous thromboembolic prophylaxis. Guidelines for adults in Argentina].
    Vázquez FJ; Lifschitz E; Watman R; Vilaseca AB; Rodríguez VE; Cruciani AJ; Korin JD; Tabares AH; Ceresetto JM; Clavier Lietti MM; Stinga CA; Bongiorno P; Princz MA; Schutz N; Barada Palmero CE; Salvador R; Canaveri A; Morón J; Pale C; Saimovici J; Capparelli FJ; Wainsztein NA; Baldessari EM; Ariscancela ME
    Medicina (B Aires); 2013; 73 Suppl 2():1-26. PubMed ID: 24192583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?
    Strebel N; Prins M; Agnelli G; Büller HR
    Arch Intern Med; 2002 Jul; 162(13):1451-6. PubMed ID: 12090880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Geerts WH; Pineo GF; Heit JA; Bergqvist D; Lassen MR; Colwell CW; Ray JG
    Chest; 2004 Sep; 126(3 Suppl):338S-400S. PubMed ID: 15383478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
    Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 36. An update on heparins at the beginning of the new millennium.
    Fareed J; Hoppensteadt DA; Bick RL
    Semin Thromb Hemost; 2000; 26 Suppl 1():5-21. PubMed ID: 11011802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Is reliable prophylaxis of postoperative venous thromboembolic complications possible?].
    Malinovskiĭ NN
    Khirurgiia (Mosk); 2001; (1):6-11. PubMed ID: 11210317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevention of venous thromboembolism in surgery, in laparoscopic surgery, in venous surgery and in urology].
    Gumulec J; Penka M; Bezdĕk R; Czudek S; Stursa M; Wróbel M; Brejcha M; Klodová D; Sumná E; Králová S
    Vnitr Lek; 2006 Mar; 52 Suppl 1():41-50. PubMed ID: 16637449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low molecular weight heparin for venous thromboembolism prophylaxis in urologic oncologic surgery.
    Sawczuk IS; Williams D; Chang DT
    Cancer Invest; 2002; 20(7-8):889-92. PubMed ID: 12449719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of venous thromboembolism: optimization by clinical trials.
    Turpie AG
    Haemostasis; 1996 Oct; 26 Suppl 4():220-6. PubMed ID: 8979127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.